
When news of the dangerous and potentially deadly side effects of Zyprexa forced the Food and Drug Administration to mandate the addition of a warning label to the bottle in 2003, many patients were left confused, frightened, and unsure of where to turn.
Zyprexa is an atypical antipsychotic prescription medication used to help manage symptoms of schizophrenia, the manic phase of manic-depression, and other psychotic disorders. Unfortunately, atypical antipsychotic drugs like Zyprexa have been shown to complicate the metabolism in some users, leading to serious blood sugar disorders like hyperglycemia and pancreatitis.
The FDA will meet on Wednesday to determine the safety to a long lasting version of Zyprexa, made by Eli Lilly.
Zyprexa has fallen under heavy scrutiny over the past few years by consumer advocacy groups and medical professionals pointing towards the dangerous and sometimes deadly side effects linked to its use; diabetes, diabetic coma, pancreatitis and in rare cases even death. There have already been two large scale rounds of thousands of lawsuits that the company has settled with plaintiff lawyers for hundreds of millions of dollars.
There will be a panel of outside experts evaluating the safety and effectiveness of the drug Zyprexa Adhera, which is an injectable version of the drug. Although many times they do, the FDA is not bound by law to follow the advice the panel of experts provides. Scientists’ of the FDA have noted that although he drug appears to work, it does seem to have an increased sedation effect among a portion of patients, which may warrant a black box warning to alert doctors and patients to the possible dangers.
Lilly states that the sedation effect is almost certainly caused by physicians performing improper injections and it not due to the drug itself.
----------------END OF FDA UPDATE ON ZYPREXA-----------
The active ingredient of Zyprexa, known as olanzapine, is believed to work by opposing the action of serotonin and dopamine transmission, two of the brain's important chemical messengers. Serotonin is involved in the regulation of sleep, appetite, sexual desire, and mood, while dopamine helps control movement, cognition, and motivation.
Zyprexa differs from older antipscyhotic drugs because it allegedly causes fewer cases of severe side effects such as extrapyramidal symptoms, tardive dyskinesia, and potentially fatal neuroleptic malignant syndrome. Atypical antipsychotic drugs were heralded from the onset because they differed from first generation antipsychotics by blocking certain neurochemical reactions within the brain, effectively alleviating the drug's negative aspects.
While these drugs did in fact reduce these chronic and often debilitating side effects, the unique neurochemistry of Zyprexa later proved to cause other unexpected and adverse reactions. Zyprexa ultimately alters the metabolism of some patients, reduces the body's sensitivity to insulin in others, and creates a host of different issues in other users.Substantial evidence has since surfaced suggesting that Eli Lilly (the maker of Zyprexa) allegedly knew about the potentially deadly side effects of Zyprexa since at least 2002 and perhaps earlier, but chose to take the path of apathy and inaction in order to protect huge profit margins. The success of Zyprexa for the company was indeed extraordinary - news reports show that the drug is currently the most popular antipsychotic medication in the United States, and Eli Lilly enjoys annual revenue of about $2.6 billion from the sale of Zyprexa.
If you've taken Zyprexa and have experienced any of these dangerous side effects, you can help ensure that innocent consumers like yourself are protected from future health scares by holding the powerful pharmaceutical companies accountable for these kinds of dangerous omissions. You may deserve to be personally compensated for your needless physical and emotional suffering caused by Zyprexa and other prescribed medications. Contact an experienced Zyprexa lawyer who knows how to navigate the complexities of personal injury law to help you what you are entitled to.
Don't let varying statute of limitations constraints impede your opportunity to take a stand against large pharmaceutical companies - read the steps below in order to learn about news and info on how to begin your free case review today.



Market Research: Antipsychotics Market Will Contract to $14 Billion by 2017
For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Antipsychotics-Patent-Expiries-Zyprexa-Abilify-6768942/ Antipsychotic drugs remain the standard care for the treatment of mental disorders such as schizophrenia and bipolar disorder.
UPDATE 2-FDA extends review of Alexza product, shares fall
Alexza Pharmaceuticals Inc said U.S. health regulators extended the review date for its novel anti-psychotic treatment by three months after the company amended its approval application , sending its shares down as much as 19 percent.
Researchers losing sleep over prescription of antipsychotics for insomnia
Canadian researchers are concerned doctors are prescribing antipsychotics - drugs once reserved for schizophrenia and mania - to patients who suffer from insomnia.
Lilly's Zyprexa Pact With Health Providers Wins Approval
Eli Lilly & Co. won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper marketing of its best-selling medication Zyprexa raised their costs.